ABSTRACT
Positron emission tomography (PET) has forwarded the development of nuclear medicine and molecular imaging through the introduction of new radiopharmaceuticals, making it possible to study physiological and biochemical processes inaccessible with other techniques. The PET technique is complex, requiring radionuclide production facilities, advanced radiochemistry, PET scanners, mathematical modeling, and trained personnel.
